Abstract
Nephrotoxicity due to renal reabsorption of radiolabeled peptides limits the tumor dose in peptide receptor radiotherapy (PRRT). Therefore, we evaluated the ability of several agents to inhibit the renal accumulation...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have